Managing SARS-CoV-2 transmission risk in workplace COVID-19 outbreaks

被引:0
|
作者
Sandys, Vince [1 ]
Simpson, Andrew [1 ]
Keen, Chris [1 ]
Chen, Yiqun [1 ]
机构
[1] Hlth & Safety Execut, Sci Div, Buxton SK17 9JN, England
关键词
control; COVID-19; risk; risk management; SARS-CoV-2; transmission; ventilation; workplace;
D O I
10.1093/annweh/wxae070
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives A Coronavirus disease 2019 (COVID-19) workplace outbreak is a risk to the health of workers and business continuity. To minimise this risk, companies have implemented risk management measures (RMMs) designed to mitigate SARS-CoV-2 transmission within the workforce. The objective of this work was to gather insights into the application of RMMs in non-healthcare workplaces and to improve understanding of the practical barriers to their implementation.Methods Data were collected using a pre-designed framework from 12 volunteer workplaces through discussions with staff responsible for site safety and during site visits to observe the RMMs and work processes. To evaluate ventilation effectiveness, measurements for carbon dioxide (CO2) were taken during the site visit and logged over an extended period in selected occupied areas.Results RMMs that were implemented well included working at home for office and other non-production staff, provision, and use of face coverings, provision for hand hygiene, and as methods became commonly available, carrying out testing for infected people. However, maintaining adequate physical distancing in many production areas proved difficult because established factory layouts cannot be easily changed and there is often a need for workers to be close to each other to communicate. A major shortcoming identified was the understanding and application of measures to improve workplace ventilation. Rapidly installing and/or upgrading mechanical ventilation systems during a pandemic may not be practical and ideally should be considered in building design. Measuring CO2 in occupied workspaces proved to be a useful tool for identifying areas with potentially inadequate ventilation.Conclusions Preventing workplace attendance by identifying infected individuals is challenging, making effective RMMs crucial to mitigating virus transmission. The effectiveness of individual RMMs can be uncertain; therefore, it is necessary to adopt multilayered RMMs. Successful implementation relies on measures that are specific to individual workplaces, identified by accurate risk assessment, regularly reviewed for effectiveness, and worker compliance. Establishing suitable risk mitigation policies and providing staff supervision are vital to ensure the sustained and effective implementation of RMMs. For RMMs that require technical understanding, such as workplace ventilation systems, specialist support may be necessary to ensure effective implementation.
引用
收藏
页码:982 / 991
页数:10
相关论文
共 50 条
  • [41] Covid-19: managing risk in the workplace
    Cooke, Tony
    VETERINARY RECORD, 2020, 187 (06) : 216 - 216
  • [42] The danger of the single storyline obfuscating the complexities of managing SARS-CoV-2/COVID-19
    Sturmberg, Joachim
    Paul, Elisabeth
    Van Damme, Wim
    Ridde, Valery
    Brown, Garrett W.
    Kalk, Andreas
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2022, 28 (06) : 1173 - 1186
  • [43] Digital PCR Applications in the SARS-CoV-2/COVID-19 Era: a Roadmap for Future Outbreaks
    Nyaruaba, Raphael
    Mwaliko, Caroline
    Dobnik, David
    Neuzil, Pavel
    Amoth, Patrick
    Mwau, Matilu
    Yu, Junping
    Yang, Hang
    Wei, Hongping
    CLINICAL MICROBIOLOGY REVIEWS, 2022, 35 (03)
  • [44] SARS-CoV-2/COVID-19-Auswirkungen auf die PlazentaImpact of SARS-CoV-2/COVID-19 on the placenta
    T. Menter
    A. Tzankov
    E. Bruder
    Der Pathologe, 2021, 42 (6): : 591 - 597
  • [45] SARS-CoV-2 and COVID-19: A Narrative Review
    Blann, A. D.
    Heitmar, R.
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2022, 79
  • [46] Perspective: SARS-CoV-2, COVID-19 and Haematologists
    Gale, Robert Peter
    ACTA HAEMATOLOGICA, 2021, 144 (02) : 117 - 120
  • [47] SARS-CoV-2 (COVID-19) and cystic fibrosis
    Stanton, Bruce A.
    Hampton, Thomas H.
    Ashare, Alix
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2020, 319 (03) : L408 - L415
  • [48] Impact of SARS-CoV-2/COVID-19 on the placenta
    Menter, T.
    Tzankov, A.
    Bruder, E.
    PATHOLOGE, 2021, 42 (06): : 591 - 597
  • [49] Computation to Fight SARS-CoV-2 (COVID-19)
    Brogi, Simone
    Calderone, Vincenzo
    COMPUTATION, 2023, 11 (09)
  • [50] SARS-CoV-2 reinfection and COVID-19 severity
    Nguyen, Nhu Ngoc
    Houhamdi, Linda
    Hoang, Van Thuan
    Delerce, Jeremy
    Delorme, Lea
    Colson, Philippe
    Brouqui, Philippe
    Fournier, Pierre-Edouard
    Raoult, Didier
    Gautret, Philippe
    EMERGING MICROBES & INFECTIONS, 2022, 11 (01) : 894 - 901